EPHB3 and neoplasm: EPHB3 controls cell positioning, restricts cell motility, and acts as a tumor suppressor. Recently, EPHB3 expression was correlated with better clinical outcomes and longer overall survival, suggesting that EPHB3 is a prognostic indicator in CRC